Compare McDonald's Corp (MCD) vs Novo Nordisk A/S (NVO) Price & Performance

McDonald's CorpTrade

Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

McDonald's Corp vs Novo Nordisk A/S — how do they compare? McDonald's Corp trades at $274 (market cap $194.00B), while Novo Nordisk A/S trades at $45.93 (market cap $207.85B). The key difference: McDonald's Corp and Novo Nordisk A/S are close in size by market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.

	MCD	NVO
Market Cap	$194.00B	$207.85B
Volume	2,230,036	—
Sector	Consumer Cyclical	Health
52-Week High	$341.06	$63.98
52-Week Low	$262.80	$35.29
Enterprise Value	$247.77B	$222.55B
Dividend Yield	2.71%	3.81%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

McDonald's Corp

McDonald's (MCD) trades at $274.15, down slightly by 0.12% on the day, with technical indicators showing a neutral overall signal. The company demonstrates strong fundamentals with consistent revenue growth, reaching $26.89 billion in 2025, and robust profitability with a 31.72% net income margin. Recent earnings have consistently beaten expectations, and the company has announced a new global growth strategy focused on automation and menu innovation to drive future performance.

The outlook for MCD is positive, supported by strong analyst consensus with a $322.45 price target implying significant upside. Key opportunities include the successful execution of its new growth plan and its defensive qualities in a challenging economy. Primary risks involve inflationary pressures on franchisee margins and intense competition in the quick-service restaurant sector.

Novo Nordisk A/S

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MCD

Invesco's PEY ETF outperforms with a dividend-growth filter, offering higher returns and reliable income.24/7 Wall Street · 18 hours agoBullish Restaurant Brands outpaces McDonald's in sales and earnings growth, with better valuation and dividends.Seeking Alpha · 1 day agoBullish Burger King overtakes Wendy's in US fast-food sales growth, challenging McDonald's dominance.24/7 Wall Street · 1 day agoNeutral View details →

NVO

Novo Nordisk downgraded to Sell on weak growth and operational issues despite strong semaglutide sales.Seeking Alpha · 5 days agoBearish View details →

About McDonald's Corp

McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.